Cargando…

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy

OBJECTIVE: To study the macular sensitivity after half-dose verteporfin photodynamic therapy in patients with resolved central serous chorioretinopathy using the automated static perimeter. METHODS: Prospective consecutive case study of 24 patients with resolved central serous chorioretinopathy was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanguansak, Thuss, Pitujaturont, Prapapan, Yospaiboon, Yosanan, Sinawat, Suthasinee, Ratanapakorn, Tanapat, Bhoomibunchoo, Chavakij
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671812/ https://www.ncbi.nlm.nih.gov/pubmed/26664040 http://dx.doi.org/10.2147/OPTH.S95748

Ejemplares similares

Infectious endophthalmitis: review of 420 cases
por: Bhoomibunchoo, Chavakij, et al.
Publicado: (2013)

Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
por: Tangtavorn, Nuanpan, et al.
Publicado: (2016)

Factors affecting visual outcomes after treatment of infectious endophthalmitis in northeastern Thailand
por: Yospaiboon, Yosanan, et al.
Publicado: (2018)

Predictive factors in the treatment of streptococcal endophthalmitis
por: Yospaiboon, Yosanan, et al.
Publicado: (2018)

Predictors for Visual Outcomes in Eye Injuries with Intraocular Foreign Body
por: Ratanapakorn, Tanapat, et al.
Publicado: (2021)

Predictors for Visual Outcome After Silicone Oil Removal in Eyes with Complicated Retinal Detachment
por: Tangpontirak, Kanpirom, et al.
Publicado: (2022)

Efficacy of Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Treatment of Large Idiopathic Full-Thickness Macular Holes
por: Sinawat, Suthasinee, et al.
Publicado: (2021)

Emulsification of Different Viscosity Silicone Oil in Complicated Retinal Detachment Surgery: A Randomized Double-Blinded Clinical Trial
por: Ratanapakorn, Tanapat, et al.
Publicado: (2020)

Oral Spironolactone versus Conservative Treatment for Non-Resolving Central Serous Chorioretinopathy in Real-Life Practice
por: Sinawat, Suthasinee, et al.
Publicado: (2020)

Laser-Induced Choroidal Neovascularizations: Clinical Study of 3 Cases
por: Laovirojjanakul, Wipada, et al.
Publicado: (2017)

Systemic abnormalities associated with retinal vein occlusion in young patients
por: Sinawat, Suthasinee, et al.
Publicado: (2017)

Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial
por: Sinawat, Suthasinee, et al.
Publicado: (2023)

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
por: Ng, Winnie WK, et al.
Publicado: (2011)

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2014)

Subretinal angiostrongyliasis-induced optic neuritis
por: Sinawat, Suthasinee, et al.
Publicado: (2013)

Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Noh, Sung Rae, et al.
Publicado: (2019)

Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
por: Iacono, Pierluigi, et al.
Publicado: (2020)

Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
por: Fujita, Kyoko, et al.
Publicado: (2020)

Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Kumashiro, Shun, et al.
Publicado: (2021)

3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
por: Hu, Yu-Chen, et al.
Publicado: (2021)

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
por: Atik, Alp, et al.
Publicado: (2017)

Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Naseripour, Masood, et al.
Publicado: (2016)

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
por: Karim, Shaheen P, et al.
Publicado: (2013)

Successful treatment of Chrysosporium keratitis with voriconazole
por: Thanathanee, Onsiri, et al.
Publicado: (2017)

Ocular angiostrongyliasis in Thailand: a retrospective analysis over two decades
por: Sinawat, Suthasinee, et al.
Publicado: (2019)

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
por: Dhirani, Nadeem Ali, et al.
Publicado: (2017)

Lower conjunctival fornix packing for mydriasis in premature infants: a randomized trial
por: Thanathanee, Onsiri, et al.
Publicado: (2012)

Digital image processing software for diagnosing diabetic retinopathy from fundus photograph
por: Ratanapakorn, Tanapat, et al.
Publicado: (2019)

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
por: Servillo, Andrea, et al.
Publicado: (2023)

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon, Mansing, et al.
Publicado: (2013)

Photodynamic Therapy and Central Serous Chorioretinopathy
por: Siaudvytyte, Lina, et al.
Publicado: (2012)

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
por: Fujita, Kyoko, et al.
Publicado: (2012)

Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
por: Alovisi, Camilla, et al.
Publicado: (2020)

Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy
por: Ma, Dae Joong, et al.
Publicado: (2018)

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
por: Horiguchi, Etsuyo, et al.
Publicado: (2022)

The impact of preprinted prescription forms on medication prescribing errors in an ophthalmology clinic in northeast Thailand: a non-randomised interventional study
por: Sanguansak, Thuss, et al.
Publicado: (2012)

Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
por: Kinoshita, Takamasa, et al.
Publicado: (2016)

Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
por: Nassisi, Marco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9gcr8h37m498u735t16nkqrmvc